Astera Labs (NASDAQ:ALAB) General Counsel Sells $231,659.88 in Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 796 shares of the stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares in the company, valued at $30,075,913.29. The trade was a 0.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Philip Mazzara also recently made the following trade(s):

  • On Monday, May 18th, Philip Mazzara sold 14,076 shares of Astera Labs stock. The stock was sold at an average price of $231.78, for a total transaction of $3,262,535.28.
  • On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00.
  • On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $349.17 on Friday. The company’s fifty day moving average price is $186.48 and its 200-day moving average price is $163.86. The firm has a market capitalization of $59.85 billion, a price-to-earnings ratio of 235.93, a PEG ratio of 4.31 and a beta of 3.35. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $354.53.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Analysts Set New Price Targets

ALAB has been the subject of a number of research reports. TD Cowen upped their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday. Royal Bank Of Canada boosted their target price on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Needham & Company LLC increased their target price on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $233.75.

View Our Latest Analysis on Astera Labs

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the period. Atreides Management LP raised its position in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. State Street Corp raised its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC raised its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the last quarter. Finally, Fred Alger Management LLC raised its position in Astera Labs by 25.5% during the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after purchasing an additional 393,250 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.